Logo Lucerna-Chem
+41 41 420 9636

Article Status


AES-135


Catalog Number Pack Size List Price* Promo Price* Quantity
HY-114483-5MG 5 mg 477,00 405,50 Add
HY-114483-10MG 10 mg 810,00 688,50 Add
HY-114483-25MG 25 mg 1'485,00 1'262,30 Add
HY-114483-50MG 50 mg 2'419,00 2'056,20 Add
HY-114483-100MG 100 mg 3'737,00 3'176,50 Add

* CHF, excl. 7.7% VAT and shipping costs


Product Description

AES-135, a hydroxamic acid-based HDAC inhibitor, prolongs survival in an orthotopic mouse model of pancreatic cancer. AES-135 inhibits HDAC3, HDAC6, HDAC8, and HDAC11 with IC50s ranging from 190-1100 nM.

Category Biochemicals
Supplier MedChem Express
Application Cancer-programmed cell death
Regulatory Status RUO
Format Solubility: DMSO : 100 mg/mL (144.16 mM; Need ultrasonic)
Grade Clinical information: No Development Reported
Purity 98.31%
Molecular Formula C33H29F6N3O5S
Molecular Weight 693.66
CAS-Number [2361659-61-0]
Storage Conditions Powder -20°C 3 years, 4°C 2 years; In solvent -80°C 6 months, -20°C 1 month
Product Line Research
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Material Safety Data Sheet Download PDF
Call us

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
From Monday through Friday
08:00 – 12:00
13:00 – 17:00

Ask us

Technical Support
tech@lucerna-chem.ch

Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

Newsletter













If you have already subscribed to our newsletter and would like to update your details or cancel it, please click here.


© Copyright 2021 Lucerna-Chem AG, Switzerland